159 related articles for article (PubMed ID: 16926677)
21. The PAI-1 4G/5G and ACE I/D polymorphisms and risk of recurrent pregnancy loss: a case-control study.
Kim JJ; Choi YM; Lee SK; Yang KM; Paik EC; Jeong HJ; Jun JK; Han AR; Hong MA
Am J Reprod Immunol; 2014 Dec; 72(6):571-6. PubMed ID: 25078885
[TBL] [Abstract][Full Text] [Related]
22. 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and insertion/deletion polymorphism of the tissue-type plasminogen activator gene in atherothrombotic stroke.
Bang CO; Park HK; Ahn MY; Shin HK; Hwang KY; Hong SY
Cerebrovasc Dis; 2001; 11(4):294-9. PubMed ID: 11385207
[TBL] [Abstract][Full Text] [Related]
23. PAI-1 4G/5G and ACE I/D gene polymorphisms and the occurrence of myocardial infarction in patients on intermittent dialysis.
Aucella F; Margaglione M; Vigilante M; Gatta G; Grandone E; Forcella M; Ktena M; De Min A; Salatino G; Procaccini DA; Stallone C
Nephrol Dial Transplant; 2003 Jun; 18(6):1142-6. PubMed ID: 12748347
[TBL] [Abstract][Full Text] [Related]
24. Tissue plasminogen activator and plasminogen activator inhibitor-1 gene polymorphisms in patients with chronic periodontitis.
Gürkan A; Emingil G; Saygan BH; Cinarcik S; Atilla G; Köse T; Berdeli A
J Periodontol; 2007 Jul; 78(7):1256-63. PubMed ID: 17608581
[TBL] [Abstract][Full Text] [Related]
25. The 4G4G genotype of the plasminogen activator inhibitor 4G/5G gene polymorphism is associated with coronary atherosclerosis in patients at high risk for this disease.
Gardemann A; Lohre J; Katz N; Tillmanns H; Hehrlein FW; Haberbosch W
Thromb Haemost; 1999 Sep; 82(3):1121-6. PubMed ID: 10494775
[TBL] [Abstract][Full Text] [Related]
26. Angiotensin converting enzyme and angiotensin II type 1-receptor gene polymorphisms and risk of ischaemic heart disease.
Rice GI; Foy CA; Grant PJ
Cardiovasc Res; 1999 Mar; 41(3):746-53. PubMed ID: 10435047
[TBL] [Abstract][Full Text] [Related]
27. Association of PAI-1 4G/5G and -844G/A gene polymorphism and changes in PAI-1/tPA levels in stroke: a case-control study.
Saidi S; Slamia LB; Mahjoub T; Ammou SB; Almawi WY
J Stroke Cerebrovasc Dis; 2007; 16(4):153-9. PubMed ID: 17689411
[TBL] [Abstract][Full Text] [Related]
28. Genetic polymorphisms and coronary artery disease in the south of France.
Canavy I; Henry M; Morange PE; Tiret L; Poirier O; Ebagosti A; Bory M; Juhan-Vague I
Thromb Haemost; 2000 Feb; 83(2):212-6. PubMed ID: 10739375
[TBL] [Abstract][Full Text] [Related]
29. Coexistence of ACE (I/D) and PAI-1 (4G/5G) gene variants in recurrent miscarriage in Polish population.
Kurzawińska G; Barlik M; Drews K; Różycka A; Seremak-Mrozikiewicz A; Ożarowski M; Klejewski A; Czerny B; Wolski H
Ginekol Pol; 2016; 87(4):271-6. PubMed ID: 27321098
[TBL] [Abstract][Full Text] [Related]
30. Plasminogen activator inhibitor-1 4G4G genotype is associated with myocardial infarction but not with stable coronary artery disease.
Onalan O; Balta G; Oto A; Kabakci G; Tokgozoglu L; Aytemir K; Altay C; Gurgey A; Nazli N
J Thromb Thrombolysis; 2008 Dec; 26(3):211-7. PubMed ID: 17721742
[TBL] [Abstract][Full Text] [Related]
31. Polymorphism of angiotensin converting enzyme gene is associated with circulating levels of plasminogen activator inhibitor-1.
Kim DK; Kim JW; Kim S; Gwon HC; Ryu JC; Huh JE; Choo JA; Choi Y; Rhee CH; Lee WR
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3242-7. PubMed ID: 9409318
[TBL] [Abstract][Full Text] [Related]
32. Multifactor dimensionality reduction analysis of MTHFR, PAI-1, ACE, PON1, and eNOS gene polymorphisms in patients with early onset coronary artery disease.
Agirbasli M; Guney AI; Ozturhan HS; Agirbasli D; Ulucan K; Sevinc D; Kirac D; Ryckman KK; Williams SM
Eur J Cardiovasc Prev Rehabil; 2011 Dec; 18(6):803-9. PubMed ID: 21450592
[TBL] [Abstract][Full Text] [Related]
33. Tissue plasminogen activator and plasminogen activator inhibitor type 1 gene polymorphism in patients with gastric ulcer complicated with bleeding.
Kim HS; Hwang KY; Chung IK; Park SH; Lee MH; Kim SJ; Hong SY
J Korean Med Sci; 2003 Feb; 18(1):58-64. PubMed ID: 12589088
[TBL] [Abstract][Full Text] [Related]
34. Insertion/deletion plasminogen activator inhibitor 1 and insertion/deletion angiotensin-converting enzyme gene polymorphisms in diabetic retinopathy in type 2 diabetes.
Globocnik-Petrovic M; Hawlina M; Peterlin B; Petrovic D
Ophthalmologica; 2003; 217(3):219-24. PubMed ID: 12660488
[TBL] [Abstract][Full Text] [Related]
35. Fibrinolytic gene polymorphism and ischemic stroke.
Jood K; Ladenvall P; Tjärnlund-Wolf A; Ladenvall C; Andersson M; Nilsson S; Blomstrand C; Jern C
Stroke; 2005 Oct; 36(10):2077-81. PubMed ID: 16179568
[TBL] [Abstract][Full Text] [Related]
36. Genetic variations of renin-angiotensin and fibrinolytic systems and susceptibility to coronary artery disease: a population genetics perspective.
Bayramoglu A; Bayramoglu G; Urhan Kucuk M; Guler HI; Arpaci A
Minerva Cardiol Angiol; 2022 Feb; 70(1):16-24. PubMed ID: 32989965
[TBL] [Abstract][Full Text] [Related]
37. Polymorphisms in the ACE and PAI-1 genes are associated with recurrent spontaneous miscarriages.
Buchholz T; Lohse P; Rogenhofer N; Kosian E; Pihusch R; Thaler CJ
Hum Reprod; 2003 Nov; 18(11):2473-7. PubMed ID: 14585904
[TBL] [Abstract][Full Text] [Related]
38. Effects of perindopril treatment on hemostatic function in patients with essential hypertension in relation to angiotensin converting enzyme (ACE) and plasminogen activator inhibitor-1 (PAI-1) gene polymorphisms.
Jastrzebskal M; Widecka K; Naruszewicz M; Ciechanowicz A; Janczak-Bazan A; Foltynska A; Goracy I; Chetstowski K; Wesotowska T
Nutr Metab Cardiovasc Dis; 2004 Oct; 14(5):259-69. PubMed ID: 15673060
[TBL] [Abstract][Full Text] [Related]
39. Role of ACE and PAI-1 Polymorphisms in the Development and Progression of Diabetic Retinopathy.
Saleem S; Azam A; Maqsood SI; Muslim I; Bashir S; Fazal N; Riaz M; Ali SH; Niazi MK; Ishaq M; Waheed NK; Qamar R; Azam M
PLoS One; 2015; 10(12):e0144557. PubMed ID: 26658948
[TBL] [Abstract][Full Text] [Related]
40. Angiotensin I-converting enzyme gene polymorphism, coronary artery disease and myocardial infarction. An angiographically controlled study.
Pfohl M; Koch M; Prescod S; Haase KK; Häring HU; Karsch KR
Eur Heart J; 1999 Sep; 20(18):1318-25. PubMed ID: 10462466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
